Irinotecan: a potential new chemotherapeutic agent for atypical or malignant meningiomas.
about
Caspase-3 and survivin expression in primary atypical and malignant meningiomasLiposomal Formulations in Clinical Use: An Updated Review.The role of neuronavigation in intracranial endoscopic procedures.Medical treatment of recurrent meningiomas.Chemotherapy: What is its role in meningioma?Medical management of meningiomas.Ventricular endoscopy in the pediatric population: review of indications.The effectiveness of microsurgical fenestration for middle fossa arachnoid cysts in children.Success of pure neuroendoscopic technique in the treatment of Sylvian arachnoid cysts in children.Pediatric intracranial arachnoid cysts: comparative effectiveness of surgical treatment options.Irinotecan side effects relieved by the use of HI-6 oxime: in vivo experimental approach.Fenestration methods for Sylvian arachnoid cysts--endoscopy or microsurgery.Stereotactic radiosurgery for WHO II and III meningiomas: analysis of long-term clinical and radiographic outcomes.Endoscopic treatment of convexity arachnoid cysts.Systemic therapy for recurrent meningioma.Endovascular treatment of a traumatic carotid artery aneurysm after endoscopic arachnoid cyst fenestration.
P2860
Q33771661-A6A7F511-0CE5-4FF3-8A23-2488EF62AEC3Q33850427-7CA904B3-3B21-4FCC-A72B-BE4D03778EC1Q36031431-ED4AABF1-298D-4958-BBC1-6C65562FFE50Q37939997-8922A710-B8EA-4380-824F-76119054184AQ38053441-1980ADAF-B2E5-4027-BFD9-AB9D24E68450Q38233448-A77AD40E-A8EE-4791-A2A4-AD6CD893178FQ38235744-844D9BDB-7A1F-4F06-9827-5493CEF860A2Q38596389-4EE45A25-6A4E-4E93-936E-AA03F358A668Q42497451-F660AC71-99FA-4E52-B9F3-39D77B7B9722Q42625182-5492F8F5-82E6-4042-810A-16CAEC370219Q43296405-F7333362-BFB3-4235-A28D-D330088A6124Q43600866-75E78A79-DC5E-4C7C-B928-9FCD1F00C1FEQ47105670-022B52A6-5830-435A-9A59-62E414BD02B4Q48296734-D2F9021E-6F9F-45DB-88AD-6097A5D93DC8Q48787594-2A19F236-BFC2-44B5-93F7-5BB4AA6B40F0Q53218155-C0355178-024A-4A04-8530-2F46B0E81DCF
P2860
Irinotecan: a potential new chemotherapeutic agent for atypical or malignant meningiomas.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Irinotecan: a potential new chemotherapeutic agent for atypical or malignant meningiomas.
@en
type
label
Irinotecan: a potential new chemotherapeutic agent for atypical or malignant meningiomas.
@en
prefLabel
Irinotecan: a potential new chemotherapeutic agent for atypical or malignant meningiomas.
@en
P2093
P1476
Irinotecan: a potential new chemotherapeutic agent for atypical or malignant meningiomas.
@en
P2093
Axel H Schönthal
Christian G Samuelson
Florence M Hofman
Leonard F Liebes
Marc C Chamberlain
Thomas C Chen
Vinay Gupta
Yuzhuang S Su
P304
P356
10.3171/JNS.2007.106.3.455
P407
P577
2007-03-01T00:00:00Z